Citrullinated Vimentin and biglycan protein fingerprints as candidate serological biomarkers for disease activity in systemic sclerosis: A pilot study.

CONCLUSION: This pilot study found differences in biomarker levels between early and late dSSc. This study offers new perspectives of ECM metabolites as potential biomarkers of dSSc. PMID: 30457356 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30457356?dopt=Abstract

Source: Biomarkers - November 22, 2018 Category: Research Tags: Biomarkers Source Type: research

More News: Research | Scleroderma | Skin | Study